V9Z-FF:

*Data is delayed | EUR
after hours iconAfter Hours: Last |
quote price arrow down ()
Close
quote price arrow down ()
52 week range
-
Loading...
  • Open-
  • Day High-
  • Day Low-
  • Prev Close-
  • 52 Week High-
  • 52 Week High Date-
  • 52 Week Low-
  • 52 Week Low Date-

Key Stats

  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open-
  • Day High-
  • Day Low-
  • Prev Close-
  • 52 Week High-
  • 52 Week High Date-
  • 52 Week Low-
  • 52 Week Low Date-
  • Market Cap-
  • Shares Out-
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On undefined

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Aceragen, Inc., formerly Idera Pharmaceuticals, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on transforming the care of people living with rare pulmonary and rheumatic diseases. Its portfolio includes late-stage programs based on biological principles that the Company is developing to be therapeutics capable of addressing the unmet medical needs of individuals living with rare diseases. The Company's pipeline includes ACG-801 and ACG-701....
Vincent Milano
Chairman of the Board
John Taylor
Chief Executive Officer, Director
Daniel Salain
Chief Operating Officer
John Kirby CPA
Chief Financial Officer, Senior Vice President
Address
505 Eagleview Boulevard, Suite 212
Exton, PA
19341
United States